OOIR: Observatory of International Research

Papers

(The median citation count of Annals of Neurology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis	362
Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)	161
Guillain‐Barré Syndrome following ChAdOx1‐S/nCoV‐19 Vaccine	157
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial	157
ANA Investigates: Neurological Complications of COVID‐19 Vaccines	148
Role of B Cells in Multiple Sclerosis and Related Disorders	145
Gut Microbiome in Progressive Multiple Sclerosis	141
Guillain–Barré Syndrome Variant Occurring after SARS‐CoV‐2 Vaccination	134
Aerobic Exercise Alters Brain Function and Structure in Parkinson's Disease: A Randomized Controlled Trial	132
COVID‐19 Vaccine Response in People with Multiple Sclerosis	120
Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi‐Omics	118
COVID‐19 Vaccine‐Associated Cerebral Venous Thrombosis in Germany	105
The Impact of SARS‐CoV‐2 on Stroke Epidemiology and Care: A Meta‐Analysis	105
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker	92
Postvaccinal Encephalitis after ChAdOx1 nCov‐19	88
Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis	86
Neurological Events Reported after COVID‐19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System	82
Preservation of Brain Activity in Unresponsive Patients Identifies MCS Star	81
Incidence, clinical, risk factors and outcomes of Guillain‐Barré in Covid‐19	81
Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease	81
SARS‐CoV‐2 and Mitochondrial Proteins in Neural‐Derived Exosomes of COVID‐19	79
Blood–Brain Barrier Breakdown in Relationship to Alzheimer and Vascular Disease	76
Magnetic ResonanceImages Implicate That Glymphatic Alterations Mediate Cognitive Dysfunction inAlzheimer Disease	74
Pediatric Ischemic Stroke: An Infrequent Complication of SARS‐CoV‐2	74
Probabilistic Mapping of Deep Brain Stimulation: Insights from 15 Years of Therapy	73

Multisystem Involvement in Post‐Acute Sequelae of Coronavirus Disease 19	72
DBS of Thalamic Centromedian Nucleus for Lennox–Gastaut Syndrome (ESTEL Trial)	70
Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019	68
An Overview of Monkeypox Virus and Its Neuroinvasive Potential	67
Inflammatory Cytokine Patterns Associated with Neurological Diseases in Coronavirus Disease 2019	67
Amylin Analog Pramlintide Induces Migraine‐like Attacks in Patients	67
Induction of Human Motor Cortex Plasticity by Theta Burst Transcranial Ultrasound Stimulation	65
Long‐Term Cognitive Outcome in Anti–N‐Methyl‐D‐Aspartate Receptor Encephalitis	65
Seizures after Ischemic Stroke: A Matched Multicenter Study	64
Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure	63
Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease	62
Long‐Term Safety and Efficacy of Eculizumab in Aquaporin‐4 IgG‐Positive NMOSD	61
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers	61
Regional Brain Growth Trajectories in Fetuses with Congenital Heart Disease	61
Meningeal CGRP‐Prolactin Interaction Evokes Female‐Specific Migraine Behavior	60
Comparative Effectiveness of Stereotactic Electroencephalography Versus Subdural Grids in Epilepsy Surgery	60
Targeting Inflammasomes to Treat Neurological Diseases	57
Characterizing the Genetic Architecture of Parkinson's Disease in Latinos	56
A Pilot Randomized, Controlled, Double‐Blind Trial of Bumetanide to Treat Neonatal Seizures	56
Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis	54
Predictors of Long‐Term Outcome of Subthalamic Stimulation in Parkinson Disease	52
Lewy Body–like Inclusions in Human Midbrain Organoids Carrying Glucocerebrosidase and α‐Synuclein Mutations	52
Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease	51
Superficial Siderosis: A Clinical Review	50
Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease	49
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development	48
Plasma p‐tau231, p‐tau181, PET Biomarkers, and Cognitive Change in Older Adults	48
Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder	48
Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART	47
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease	47
Electroencephalographic Abnormalities are Common inCOVID‐19 and are Associated with Outcomes	45
Axon‐Myelin Unit Blistering as Early Event in MS Normal Appearing White Matter	45
Antibodies Contributing to Focal Epilepsy Signs and Symptoms Score	45
Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model	45
7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions	44
Contributors to SerumNfLLevels in People without Neurologic Disease	44
Socioeconomic Status Mediates Racial Differences Seen Using theAT(N)Framework	44
Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome	43
Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease	42
Neuropathological Variability within a Spectrum of NMDAR‐Encephalitis	41
Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study	41
Heritability Enrichment Implicates Microglia in Parkinson's Disease Pathogenesis	41
EIF2AK2 Missense Variants Associated with Early Onset Generalized Dystonia	41
Adoptive Transfer of JC Virus‐Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy	40
A New AdvancedMRIBiomarker for Remyelinated Lesions in Multiple Sclerosis	40
Detection of Brain Somatic Mutations in Cerebrospinal Fluid from Refractory Epilepsy Patients	40
Selective Endothelial Hyperactivation of Oncogenic KRAS Induces Brain Arteriovenous Malformations in Mice	40
Adults with Cerebral Palsy Require Ongoing Neurologic Care: A Systematic Review	40
Covert Speech Comprehension Predicts Recovery From Acute Unresponsive States	39
Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study	39

Silent New Brain MRI Lesions in Children with MOG‐Antibody Associated Disease	38
Complement Activation Is a Prominent Feature of MOGAD	38
Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease	37
NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages	37
Diagnostic Accuracy of Amyloid versus¹⁸F‐Fluorodeoxyglucose Positron Emission Tomography inAutopsy‐ConfirmedDementia	37
Genome‐Wide Association Study Identifies Risk Loci for Cluster Headache	36
Decreased Frontal Gamma Activity in Alzheimer Disease Patients	35
Very Low Residual Dystrophin Quantity Is Associated with Milder Dystrophinopathy	35
Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease	34
Risk Factors for Phenoconversion in Rapid Eye Movement Sleep Behavior Disorder	34
Cytokines inNew‐OnsetRefractory Status Epilepticus Predict Outcomes	34
Leucine‐Rich Glioma‐Inactivated 1 versus Contactin‐Associated Protein‐like 2 Antibody Neuropathic Pain: Clinical and Biological Comparisons	34
Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine	33
α‐Synuclein Seed Amplification in CSF and Brain from Patients with Different Brain Distributions of Pathological α‐Synuclein in the Context of Co‐Pathology and Non‐LBD Diagnoses	33
Brain Structure and Degeneration Staging in Friedreich Ataxia: Magnetic Resonance Imaging Volumetrics from the ENIGMA‐Ataxia Working Group	33
B Cell Depletion and SARS‐CoV‐2 Vaccine Responses in Neuroimmunologic Patients	33
Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker	33
Noninvasive Mapping of Ripple Onset Predicts Outcome in Epilepsy Surgery	32
Subicular Caspase‐1 Contributes to Pharmacoresistance in Temporal Lobe Epilepsy	32
Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2	32
“Ependymal‐in” Gradient of Thalamic Damage in Progressive Multiple Sclerosis	32
Blood Metal Levels and Amyotrophic Lateral Sclerosis Risk: A Prospective Cohort	32
Subtype Diagnosis of Sporadic Creutzfeldt–Jakob Disease with Diffusion Magnetic Resonance Imaging	31
Perfusion Imaging and Clinical Outcome in Acute Ischemic Stroke with Large Core	31
Longitudinal Changes in Hippocampal Network Connectivity in Alzheimer's Disease	31
Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease	31
Cerebrospinal Fluid Analysis Post–COVID‐19 Is Not Suggestive of Persistent Central Nervous System Infection	31
Staufen1 in Human Neurodegeneration	30
A Subpopulation of Spikes Predicts Successful Epilepsy Surgery Outcome	30
Association between Migraine and Cryptogenic Ischemic Stroke in Young Adults	30
Genetic Susceptibility Loci in Genomewide Association Study of Cluster Headache	30
A Prodromal Brain‐Clinical Pattern of Cognition in Synucleinopathies	29
Perfusion Imaging Predicts Favorable Outcomes after Basilar Artery Thrombectomy	29
Common X‐Chromosome Variants Are Associated with Parkinson Disease Risk	29
Prediction Model of Amyotrophic Lateral Sclerosis by Deep Learning with Patient Induced Pluripotent Stem Cells	29
Non–Cell Autonomous Epileptogenesis in Focal Cortical Dysplasia	29
Parkinson's Disease Derived Exosomes Aggravate Neuropathology in SNCA*A53T Mice	29
Longitudinal Retinal Changes in MOGAD	29
Sorbitol Is a Severity Biomarker for PMM2‐CDG with Therapeutic Implications	28
Personalizing Deep Brain Stimulation Using Advanced Imaging Sequences	28
Microglial Activation and Connectivity in Alzheimer Disease and Aging	28
Positron Emission Tomography with [¹⁸F]‐DPA‐714 Unveils a Smoldering Component in Most Multiple Sclerosis Lesions which Drives Disease Progression	27
Tuber Locations Associated with Infantile Spasms Map to a Common Brain Network	27
Characterization of the Insular Role in Cardiac Function through Intracranial Electrical Stimulation of the Human Insula	27
Hydroxychloroquine for Primary Progressive Multiple Sclerosis	27
Postictal Death Is Associated with Tonic Phase Apnea in a Mouse Model of Sudden Unexpected Death in Epilepsy	27
Changing Gears – DBS For Dopaminergic Desensitization in Parkinson's Disease?	27
Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab	27
Subthalamic and Pallidal Stimulations in Patients with Parkinson's Disease: Common and Dissociable Connections	27
Single Photon Emission Computed Tomography/Positron Emission Tomography Molecular Imaging for Parkinsonism: A Fast‐Developing Field	27
Endovascular Thrombectomy Versus Medical Management in Isolated M2 Occlusions: Pooled Patient‐Level Analysis from the EXTEND‐IA Trials, INSPIRE, and SE	26
Multicenter Validation of the max‐ICH Score in Intracerebral Hemorrhage	26
Circulating microRNAs Associated With Reversible Cerebral Vasoconstriction Syndrome	26
Risk Factors and Incidence of Epilepsy after Severe Traumatic Brain Injury	26
The Optimal Target and Connectivity for Deep Brain Stimulation in Lennox–Gastaut Syndrome	26
Cortical Correlates of Gait Compensation Strategies in Parkinson Disease	25
Iron Heterogeneity in Early Active Multiple Sclerosis Lesions	25
Targeted tDCS Mitigates Dual‐Task Costs to Gait and Balance in Older Adults	25
Childhood Neurotoxicity and Brain Resilience to Adverse Events during Adulthood	25
ZSCAN1 Autoantibodies Are Associated with Pediatric Paraneoplastic ROHHAD	25
Anti‐Neuronal Nuclear Antibody 3 Autoimmunity Targets Dachshund Homolog 1	25
A Novel Multisystem Proteinopathy Caused by a Missense ANXA11 Variant	24
Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors	24
Perfusion‐Dependent Cerebral Autoregulation Impairment in Hemispheric Stroke	24
T_max Volumes Predict Final Infarct Size and Functional Outcome in Ischemic Stroke Patients Receiving Endovascular Treatment	24
An Apple a Day to Keep the Parkinson's Disease Doctor Away?	24
Advances in Treatment of Progressive Multifocal Leukoencephalopathy	24
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by SerumNfLandpNfH: A Longitudinal Multicentre Study	24
Frailty and Risk of Dementia in Mild Cognitive Impairment Subtypes	24
Regional Precuneus Cortical Hyperexcitability in Alzheimer's Disease Patients	23
Deep Brain Stimulation for Arm Tremor: A Randomized Trial Comparing Two Targets	23
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations	23
GGC Repeat Expansion of RILPL1 is Associated with Oculopharyngodistal Myopathy	23
Regional Glymphatic Abnormality in Behavioral Variant Frontotemporal Dementia	23
Automated Annotation of Epileptiform Burden and Its Association with Outcomes	23
Tau‐Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer's Disease	23
CD8⁺ T‐Lymphocyte–Driven Limbic Encephalitis Results in Temporal Lobe Epilepsy	23
Cluster Headache Genomewide Association Study and Meta‐Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor	23
Multimodal Biomarkers Quantify Recovery in Autoimmune Autonomic Ganglionopathy	22
Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale	22

Motor Progression and Nigrostriatal Neurodegeneration in Parkinson Disease	22
Personalized fMRI Delineates Functional Regions Preserved within Brain Tumors	22
GIPC1 CGG Repeat Expansion Is Associated with Movement Disorders	22
MRI Clustering Reveals Three ALS Subtypes With Unique Neurodegeneration Patterns	22
Proinflammatory CD20⁺ T Cells are Differentially Affected by Multiple Sclerosis Therapeutics	22
Human Endogenous Retrovirus K Envelope in Spinal Fluid of Amyotrophic Lateral Sclerosis Is Toxic	22
Lipids, Apolipoproteins, Statins, and Intracerebral Hemorrhage: A Mendelian Randomization Study	22
Natural History of Leigh Syndrome: A Study of Disease Burden and Progression	22
Magnetic Resonance Imaging Evaluation of Perivascular Space Abnormalities in Neuromyelitis Optica	22
Characterization of the GABRB2‐Associated Neurodevelopmental Disorders	22
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID‐19 Vaccination	22
Human CASPR2 Antibodies Reversibly Alter Memory and the CASPR2 Protein Complex	22
Circadian Rest–Activity Rhythms, Delirium Risk, and Progression to Dementia	21
Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease‐Modifying Therapies: A Multi‐Ethnic Observational Study	21
Association between Human Blood Metabolome and the Risk of Alzheimer's Disease	21
Guillain‐Barré Syndrome in an Australian State Using Both mRNA and Adenovirus‐Vector SARS‐CoV‐2 Vaccines	21
147th Annual Meeting American Neurological Association	21
Choroid Plexus Enlargement Exacerbates White Matter Hyperintensity Growth through Glymphatic Impairment	21
Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS	21
Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype	20
Human Brain Resilience: A Call to Action	20
A Causal Classification System for Intracerebral Hemorrhage Subtypes	20
Multisite Study of Evoked Potentials in Rett Syndrome	20
A Combined Panel of Salivary Biomarkers in de novo Parkinson's Disease	20
Deep Learning Applications for Acute Stroke Management	20
Delandistrogene Moxeparvovec Gene Therapy in Ambulatory Patients (Aged ≥4 to <8 Years) with Duchenne Muscular Dystrophy: 1‐Year Interim Results from Study SRP‐9001‐103 (ENDEAVOR	20
Association of Presynaptic Loss with Alzheimer's Disease and Cognitive Decline	20
Probabilistic Mapping Reveals Optimal Stimulation Site in Essential Tremor	20
Infratentorial Superficial Siderosis and Spontaneous Intracranial Hypotension	20
Novel Autoantibodies in Idiopathic Small Fiber Neuropathy	19
Optimal Surgical Extent for Memory and Seizure Outcome in Temporal Lobe Epilepsy	19
Synaptic Loss in Frontotemporal Dementia Revealed by [¹¹C]UCB‐J Positron Emission Tomography	19
Recording of Ictal Epileptic Activity Using on‐Scalp Magnetoencephalography	19
International Validation of the Erasmus Guillain–Barré Syndrome Respiratory Insufficiency Score	19
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis	19
Variants in Mitochondrial ATP Synthase Cause Variable Neurologic Phenotypes	19
Retinal INL Thickness in Multiple Sclerosis: A Mere Marker of Neurodegeneration?	19
Neurofilament Light Chain in Patients with COVID‐19 and Bacterial Pneumonia	19
miR‐146b Protects the Perinatal Brain against Microglia‐Induced Hypomyelination	19
APOE Antibody Inhibits Aβ‐Associated Tau Seeding and Spreading in a Mouse Model	19
Mitochondrial DNA Analysis from Exome Sequencing Data Improves Diagnostic Yield in Neurological Diseases	19
Subcortical Volumes as Early Predictors of Fatigue in Multiple Sclerosis	19
5‐Year Associations among Cerebral Arterial Pulsatility, Perivascular Space Dilation, and White Matter Lesions	19
Tregs Attenuate Peripheral Oxidative Stress and Acute Phase Proteins inALS	19
Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy	19
Prolonged Unconsciousness is Common in COVID‐19 and Associated with Hypoxemia	18
Neurologic Manifestations of Long COVID Differ Based on Acute COVID‐19 Severity	18
Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset	18
Multiple SclerosisIs Rare in Epstein–Barr Virus–Seronegative Children withCentral Nervous SystemInflammatory Demyelination	18
Profile of Autism Spectrum Disorder in Tuberous Sclerosis Complex: Results from a Longitudinal, Prospective, Multisite Study	18
Neocortical Lewy Body Pathology Parallels Parkinson's Dementia, but Not Always	18
Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral Sclerosis	18
Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease	17
Long‐Duration Progressive Supranuclear Palsy: Clinical Course and Pathological Underpinnings	17
Biomarkers of Migraine and Cluster Headache: Differences and Similarities	17
Adjunct Thrombolysis Enhances Brain Reperfusion following Successful Thrombectomy	17
Cardiac Investigations in Sudden Unexpected Death in DEPDC5‐Related Epilepsy	17
Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis	17
Onset of Preclinical Alzheimer Disease in Monozygotic Twins	17
COVID‐19‐Associated Critical Illness Myopathy with Direct Viral Effects	17
Approaches to Understanding COVID‐19 and its Neurological Associations	17
Association between Computed Tomographic Biomarkers of Cerebral Small Vessel Diseases and Long‐Term Outcome after Spontaneous Intracerebral Hemorrhage	17
Effect Modification between Genes and Environment and Parkinson's Disease Risk	17
Thrombectomy versus Medical Management in Mild Strokes due to Large Vessel Occlusion: Exploratory Analysis from the EXTEND‐IA Trials and a Pooled International Cohort	17
Venous Collagenosis as Pathogenesis of White Matter Hyperintensity	17
Postictal Psychosis in Epilepsy: A Clinicogenetic Study	16
Associations of Vascular Risk and Amyloid Burden with Subsequent Dementia	16
COVID‐19 Induces Neuroinflammation and Suppresses Peroxisomes in the Brain	16
Sleep Deprivation Exacerbates Seizures and Diminishes GABAergic Tonic Inhibition	16
Re‐Emergence of Poliovirus in the United States: Considerations and Implications	16
Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke	16
Timeline of Rapid Eye Movement Sleep Behavior Disorder in Overt Alpha‐Synucleinopathies	16
Determinants of Infarct Core Growth During Inter‐hospital Transfer for Thrombectomy	16
Polygenic Risk Score for Alzheimer's Disease in Caribbean Hispanics	16
Time from I.V. Thrombolysis to Thrombectomy and Outcome in Acute Ischemic Stroke	16
PPP2R5D Genetic Mutations and Early‐Onset Parkinsonism	16
Genome‐Wide Analysis of Structural Variants in Parkinson Disease	16
Reduced Numbers of Corticotropin‐Releasing Hormone Neurons in Narcolepsy Type 1	16
CADASIL Affects Multiple Aspects of Cerebral Small Vessel Function on 7T‐MRI	15
Truncating VPS16 Mutations Are Rare in Early Onset Dystonia	15
Early Predictors of Clinical andMRIOutcomes UsingLeast Absolute Shrinkage and Selection Operator (LASSO)in Multiple Sclerosis	15
Clinically Meaningful Magnetic Resonance Endpoints Sensitive to Preataxic Spinocerebellar Ataxia Types 1 and 3	15
Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency	15
Feasibility and Validity of the Coma Recovery Scale‐Revised for Accelerated Standardized Testing: A Practical Assessment Tool for Detecting Consciousness in the Intensive Care Unit	15
DNase Treatment Prevents Cerebrospinal Fluid Block in Early Experimental Pneumococcal Meningitis	15
Genetic Variation in WNT9B Increases Relapse Hazard in Multiple Sclerosis	15
Adenovirus COVID‐19 Vaccines and Guillain–Barré Syndrome with Facial Paralysis	15
Beware of Optimism Bias in the Context of the COVID‐19 Pandemic	15
Human Oligodendrocyte Myelination Potential; Relation to Age and Differentiation	15
A Transcriptome‐Based Drug Discovery Paradigm for Neurodevelopmental Disorders	15
Leigh Syndrome: A Study of 209 Patients at the Beijing Children's Hospital	15
Monogenic Causes of Apparently Idiopathic Perinatal Intracranial Hemorrhage	15
Plasma Metabolites Link Dietary Patterns to Stroke Risk	15
Tenecteplase Improves Reperfusion across Time in Large Vessel Stroke	15
Magnetic Resonance Imaging Correlates of Multiple Sclerosis Immunopathological Patterns	15